Relypsa, Inc. (NASDAQ: RLYP) announced that the company has submitted a supplemental New Drug Application (sNDA) to the U.S. Food ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE